Delivery Order SPE2DB22D3501-SPE2DB25FWM45
- Not listed
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract worth $2,252.46 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 1.5 gram/1.5 milliliter vials of the drug fomepizole. This single award contract has a completion date of February 8, 2024 and does not include any set-aside designations. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is issued under a...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical company AmerisourceBergen Corporation. The contract is for the supply of Fomepizole 1.5 GM/1.5 ML vials, a critical care medication, with a ceiling value of $6,144.40 and a performance period through March 14, 2024. AmerisourceBergen Drug Corp serves as a prime contractor for DLA, providing a wide range of...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,054.28 Firm Fixed Price Delivery Order is for the supply of 4566682365 FOMEPIZOLE 1.5 GM/1.5 ML VIAL 1.5ML, with a final delivery date of December 12, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
- This federal contract award to Amerisourcebergen Drug Corp, a pharmaceutical distributor and healthcare solutions provider, was issued by the Defense Logistics Agency (DLA). The $1,279.46 firm fixed-price delivery order is for the supply of FOMEPIZOLE 1.5 GM/1.5 ML VIAL 1.5ML, a specialized medical product, with a completion date of June 5, 2025. The contract is not set-aside and was awarded on June 4, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
- This is a $1,664.50 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4566681918 - FOMEPIZOLE 1.5 GM/1.5 ML VIAL 1.5ML and has an ultimate completion date of December 12, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary vehicle for...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,028.79 firm fixed-price delivery order is for the supply of 4568199747 - FOMEPIZOLE 1.5 GM/1.5 ML VIAL 1.5ML, with a period of performance through May 12, 2025. The contract is not set-aside and was awarded on May 9, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery...
- The Defense Logistics Agency Troop Support Medical awarded a $321.79 firm fixed price delivery order to Amerisourcebergen Drug Corp Corporate Office Division for 4561879909, 1.5 grams/1.5 milliliter vials of fomepizole. Performance will take place in Conshohocken, Pennsylvania. The single day order from August 21st to August 22nd, 2023 is being fulfilled under an existing indefinite delivery/indefinite quantity contract vehicle held by Amerisourcebergen Corporation, the parent company of...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of FOMEPIZOLE 1.5 GM/1.5 ML VIAL 1.5ML. The contract has a firm fixed price of $3,640.66 and a completion date of July 12, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a firm fixed price delivery order contract by the Defense Logistics Agency (DLA) Troop Support Medical to provide 1.5 gram/1.5 milliliter vials of the pharmaceutical drug fomepizole. The potential value of this contract is $1,287.16 and it has a completion date of January 26, 2024. This delivery order contract is associated with an indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Fomepizole 1.5 GM/1.5 ML Vials, a medication used in the treatment of certain types of poisoning. The contract has a firm fixed price of $2,257.27 and a period of performance through June 24, 2025. It is not designated as a set-aside contract, indicating open competition....
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB25FWM45Delivery Order
The Defense Logistics Agency awarded a $1,887.94 delivery order to AmerisourceBergen Drug Corp for the supply of Fomepizole 1.5 gm/1.5 ml vials on July 21, 2025, with an ultimate completion date of July 22, 2025. The award is structured as a firm fixed-price contract with no set-aside designation, indicating competitive award status. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order represents a discrete purchase under the company's broader relationship with the Defense Logistics Agency's medical supply chain. This delivery order is issued under AmerisourceBergen Drug Corp's Indefinite Delivery Contract (IDC) SPE2DX with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen Drug Corp supplies a comprehensive range of pharmaceutical products and medical supplies to support military healthcare systems and other government agencies. The Fomepizole product supports the Defense Health Agency and related government healthcare systems' medical supply needs through this expansive global pharmaceutical support vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 7/21/25 |